Yes, Alzheimer’s disease can cause hallucinations, though they typically appear in the moderate to later stages rather than early on. Roughly 12 to 25 percent of people with Alzheimer’s experience hallucinations at some point during the disease, most commonly visual ones. Understanding why they happen, what they look like, and what can be done about them matters enormously for both the person experiencing them and anyone providing care.
When Hallucinations Typically Appear
Hallucinations in Alzheimer’s are not an early symptom. They tend to emerge during the moderate stage, when behavioral changes like agitation, delusions, and disinhibition also become more pronounced. As the disease progresses into later stages, hallucinations can become more frequent and harder to manage. This timeline is one of the clearest ways Alzheimer’s hallucinations differ from those caused by other forms of dementia.
If someone in the early stages of memory loss begins having vivid, well-formed visual hallucinations, that pattern actually points more toward Lewy body dementia than Alzheimer’s. This distinction matters for diagnosis and treatment, so it’s worth flagging for a healthcare provider.
What Causes Them in the Brain
Alzheimer’s gradually destroys brain tissue, and the specific areas it damages help explain why hallucinations develop. Research using brain imaging has linked hallucinations to thinning of the supramarginal area in the parietal lobe, a region involved in integrating sensory information. When this area atrophies, the brain struggles to correctly process what it sees, hears, and feels.
Two chemical messaging systems in the brain also play a role. Serotonin levels drop in parts of the brain involved in visual processing and memory, and the neurons that produce serotonin in the brainstem degenerate. At the same time, the cholinergic system, which supports attention and awareness, deteriorates. Studies have found reduced cholinergic activity specifically in Alzheimer’s patients who hallucinate compared to those who don’t. Together, these chemical disruptions leave the brain more likely to generate false perceptions.
What the Hallucinations Look Like
In Alzheimer’s, hallucinations are most often visual. A person might see people who aren’t there, animals, or unfamiliar objects in the room. Compared to Lewy body dementia, where hallucinations tend to be vivid and detailed (small people, children, furry animals), Alzheimer’s hallucinations are generally less well-formed and less elaborate. Auditory hallucinations, like hearing voices or sounds, can also occur but are less common.
The person experiencing them often believes they are completely real. Unlike someone with Charles Bonnet syndrome, a condition where vision loss triggers hallucinations but the person knows the images aren’t real, people with moderate or advanced Alzheimer’s usually lack that insight. This can make the experience frightening and disorienting, and it’s a major reason hallucinations are so distressing for caregivers to witness.
Medical Triggers That Mimic or Worsen Hallucinations
Not every hallucination in someone with Alzheimer’s is caused by the disease itself. A sudden onset of hallucinations, especially if they appear for the first time or dramatically worsen, can signal a treatable medical problem. The most common culprit is delirium, a state of acute confusion triggered by something going wrong in the body.
Infections are the most frequent cause of delirium in older adults, responsible for nearly half of all cases. Urinary tract infections are particularly tricky because they often present without the classic symptoms like burning or fever. Instead, an older person with a UTI may become suddenly confused, drowsy, agitated, or start hallucinating. Other common triggers include dehydration, electrolyte imbalances, medication side effects, low blood sugar, and thyroid problems.
This is important to recognize because delirium-related hallucinations can often be resolved by treating the underlying cause. A sudden change in behavior always warrants a medical evaluation, even in someone who already has Alzheimer’s.
The Role of Vision and Hearing Loss
Sensory loss adds another layer. When the brain receives less input from the eyes or ears, it becomes more likely to fill in the gaps with false perceptions. Conditions like macular degeneration, glaucoma, and diabetic retinopathy reduce the visual information reaching the brain. In response, visual processing areas become overactive and can generate spontaneous images like figures, animals, or patterns.
Many people with Alzheimer’s are also older adults dealing with significant vision or hearing decline. If glasses are dirty or the wrong prescription, or hearing aids aren’t working properly, the brain receives even less reliable sensory data. This compounds the hallucination risk already created by the disease. Simply ensuring that corrective devices are clean, functional, and consistently used can make a meaningful difference.
Environmental Changes That Help
Because Alzheimer’s hallucinations are partly driven by the brain misinterpreting sensory input, adjusting the environment can reduce how often they occur. Lighting is one of the most important factors. Dim rooms and shadows are frequently misperceived, causing anxiety or triggering visual hallucinations. Keeping living spaces well-lit, especially during evening hours when confusion tends to worsen, helps the brain process its surroundings more accurately.
Other practical changes include reducing clutter, keeping decorations simple and familiar, and minimizing background noise. Auditory overstimulation can contribute to confusion and agitation. Spaces where the person walks or spends time should be clear and easy to navigate. The goal is to create an environment that gives the brain as much reliable, consistent sensory information as possible, reducing the chances it generates something false.
Structured routines, music therapy, and calm, reassuring responses when hallucinations do occur are all part of the non-drug toolkit. If someone is seeing something that isn’t there, arguing or correcting them usually increases distress. Acknowledging their experience calmly and redirecting their attention is generally more effective.
Medication Options and Their Risks
There is currently no FDA-approved medication specifically for hallucinations in Alzheimer’s. The one drug approved for behavioral symptoms in Alzheimer’s, brexpiprazole, targets agitation rather than hallucinations directly, though it works by regulating serotonin and dopamine activity. Research into a drug called pimavanserin, which blocks a specific serotonin receptor involved in psychosis, has shown promise for treating hallucinations and delusions in Alzheimer’s, but the treatment landscape remains limited.
Antipsychotic medications are sometimes used off-label for severe hallucinations, but they carry serious risks in this population. The FDA issued black box warnings after a meta-analysis of 17 clinical trials found that older adults with dementia who took atypical antipsychotics had 1.6 to 1.7 times the risk of death compared to those taking a placebo. Over a typical 10-week trial, 4.5 percent of those on the medication died compared to 2.6 percent on placebo. The deaths were primarily cardiovascular events and infections like pneumonia. There is also an increased risk of stroke. These warnings apply to the entire class of atypical antipsychotics.
This doesn’t mean antipsychotics are never used. In cases where hallucinations cause severe distress or dangerous behavior, the potential benefit may outweigh the risks. But it’s a decision that requires careful consideration, and non-drug approaches should typically be tried first.
Alzheimer’s Hallucinations vs. Lewy Body Dementia
The timing and character of hallucinations can help distinguish between these two diseases. In Lewy body dementia, vivid, detailed visual hallucinations are a core feature and often appear early, sometimes before significant memory loss. People may see small people, children, or animals with striking clarity. In Alzheimer’s, hallucinations are less common overall, less vivid, and emerge later in the disease course.
This distinction has practical importance. Lewy body dementia makes people extremely sensitive to antipsychotic medications, which can cause life-threatening reactions. If early, vivid hallucinations are a prominent symptom, getting the correct diagnosis is critical because it changes which treatments are safe to use.